Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide--Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).
Entry Term(s)
ACE1 Angiotensin-Converting Enzyme 1
ACE1 Protein
Angiotensin Converting Enzyme
Angiotensin Converting Enzyme 1
Angiotensin I-Converting Enzyme
Antigens, CD143
CD143 Antigens
Carboxycathepsin
Dipeptidyl Carboxypeptidase I
Dipeptidyl Peptidase A
Kininase A
Kininase II
Peptidase P
Registry Numbers
EC 3.4.15.1
Previous Indexing
Peptide Peptidohydrolases (1966-1972)
Public MeSH Note
1994; see KININASE II 1974-93; for TONIN see KININASE II 1984-93
A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide--Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020).